Mulberry leaf extract multivesicular liposome, preparation method, health food and hypoglycemic application of mulberry leaf extract multivesicular liposome

Through polycystic liposome technology, the mulberry leaf flavonoids and mulberry leaf alkaloid DNJ were embedded, and the problems of insoluble and poor stability of the dual-effect components in the aqueous solution system in the prior art were solved, and the efficient glycemic reduction effect of mulberry leaf extracts was achieved. Simplified process.

CN118947905AActive Publication Date: 2024-11-15XIAN NUOZHONGKANGJIAN BIOTECHNOLOGY CO LTD

Patent Information

Application Number
CN202411079258.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-15
Estimated Expiration
2044-08-07

AI Technical Summary

Technical Problem

In the prior art, mulberry leaf flavonoids and mulberry leaf alkaloid DNJ are insoluble or have poor stability in aqueous solution system, and there is residual organic solvent, the process takes a long time and is expensive, and the dual-function components are not effectively embedded, which affects the effect of reducing sugar.

Method used

Using polycystic liposome technology, mulberry leaf flavonoids are encapsulated in a lipid bilayer, mulberry leaf alkaloid DNJ is encapsulated in an aqueous chamber, and mulberry leaf extract polycystic lipids are prepared by shearing and spray drying. to form powdery products, improve bioavailability and sustained release effect.

Benefits of technology

The effective embedding of flavonoids and mulberry leaves DNJ is achieved, which improves bioavailability and sustained release effect, solves the problems of low bioavailability and short half-life, significantly improves the effect of sugar reduction, and simplifies the process and reduces the cost.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118947905A_ABST
    Figure CN118947905A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of food health care, in particular to mulberry leaf extract multivesicular liposome, a preparation method, health care food and hypoglycemic application of the mulberry leaf extract multivesicular liposome. The mulberry leaf extract multivesicular liposome comprises a mulberry leaf extract and a blank multivesicular liposome, the mulberry leaf extract contains mulberry leaf flavone and mulberry leaf alkaloid; the blank multivesicular liposome is composed of lipid bilayers, and the interior of the blank multivesicular liposome comprises a plurality of water-based chambers which are separated by the lipid bilayers; wherein the mulberry leaf flavone is located between lipid bilayers, and the mulberry leaf alkaloid is located in the water-based chamber. According to the mulberry leaf extract multivesicular liposome provided by the invention, embedding of mulberry leaf flavone and mulberry leaf alkaloid can be realized at the same time, so that the effect of reducing blood sugar is better achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of food health care, and in particular to a mulberry leaf extract multivesicular liposome, a preparation method, a health food and a blood sugar-lowering application thereof. Background Art

[0002] Mulberry leaves are the dried leaves of the mulberry plant (Mours alba L) of the Moraceae family. They have a long history of use as a common Chinese medicine in my country. The Compendium of Materia Medica records that "the juice can be boiled instead of tea to cure thirst". Modern pharmacological studies have also shown that mulberry leaves have multiple pharmacological effects such as lowering blood sugar, lowering blood lipids, lowering blood pressure, anti-oxidation, anti-inflammatory, and regulating the body's immunity, among which the blood sugar lowering effect is the most prominent. At present, mulberry leaves can be used as medicine and can also be eaten. They have been listed in the list of medicine and food homology by my country's health department and have important medicinal and edible value.

[0003] It has been reported that mulberry leaf flavonoids and mulberry leaf alkaloids DNJ are the main hypoglycemic active ingredients, which can inhibit the activity of disaccharidase (sucrase, isomaltase, maltase) in the small intestine and are good α-glucosidase inhibitors. In addition, mulberry leaf flavonoids and alkaloids DNJ can also stimulate the secretion of GLP-1 in the small intestine, and reduce blood sugar through multiple ways such as promoting insulin secretion in the body, delaying gastric emptying, strengthening central appetite suppression and reducing food intake.

[0004] Mulberry leaf flavonoids are mainly composed of rutin, quercetin and kaempferol nuclei. Their poor water solubility and absorption make their bioavailability extremely low. Although mulberry leaf alkaloid DNJ is a water-soluble substance, its half-life in the human body is short, about 2 hours, which affects the continuous control of blood sugar. The low bioavailability of mulberry leaf flavonoids and the short half-life of mulberry leaf alkaloid DNJ will affect the final hypoglycemic effect of mulberry leaf to a certain extent.

[0005] Chinese patent document CN109350746A discloses a method for preparing a 1-deoxynojirimycin (i.e., mulberry alkaloid DNJ) sustained-release preparation with mulberry leaf polysaccharide as a carrier, comprising the following steps: first synthesizing Pluronic-polyethyleneimine PEI, then synthesizing Pluronic-polyethyleneimine PEI-phenylboronic acid PBA, then synthesizing Pluronic-polyethyleneimine PEI-phenylboronic acid PBA-medicine mulberry leaf polysaccharide nanocarrier, and finally obtaining a 1-deoxynojirimycin sustained-release preparation; Chinese patent document CN115252677A discloses a mulberry leaf prebiotic based on intestinal probiotics to regulate blood sugar homeostasis and a preparation method thereof, which embeds mulberry leaf alkaloids and mulberry leaf polysaccharides in a gel manner to achieve the purpose of sustained-release of mulberry leaf alkaloids. However, the above patents do not involve the embedding of the dual-functional components of mulberry leaf flavonoids and mulberry leaf alkaloid DNJ; therefore, there is an urgent need for a method that can effectively embed mulberry leaf flavonoids and mulberry leaf alkaloid DNJ. Summary of the invention

[0006] The purpose of the present invention is to provide a mulberry leaf extract multivesicular liposome, a preparation method, a health food and its hypoglycemic application, so as to overcome the problems existing in the prior art of mulberry leaf flavonoids and mulberry leaf alkaloid DNJ dual-functional ingredients being insoluble in aqueous solution system or having poor stability and easy precipitation, having residual organic solvent, having long process time and high cost.

[0007] According to the first aspect of this aspect, the present invention provides a mulberry leaf extract multivesicular liposome, the mulberry leaf extract multivesicular liposome comprises mulberry leaf extract and blank multivesicular liposome; the mulberry leaf extract comprises mulberry leaf flavonoids and mulberry leaf alkaloids; the blank multivesicular liposome is composed of a lipid bilayer, the blank multivesicular liposome contains a plurality of aqueous chambers inside and the aqueous chambers are separated by the lipid bilayers; wherein the mulberry leaf flavonoids are located between the lipid bilayers, and the mulberry leaf alkaloids are located within the aqueous chambers.

[0008] In one aspect of the present invention, the blank multivesicular liposomes have a particle size of 10-60 μm.

[0009] In one aspect of the present invention, in the mulberry leaf extract multivesicular liposomes, the mass ratio of the mulberry leaf extract to blank multivesicular liposomes is selected from 1:1-1:5.

[0010] In one aspect of the present invention, the mulberry leaf flavonoids include compounds such as rutin (vitamin P, rutin), quercetin, isoquercetin, quercetin-3-triglucoside, and the like.

[0011] In one aspect of the present invention, the mulberry leaf alkaloids include mulberry leaf DNJ (1-deoxynojirimycin), N-methyl-1-DNJ (N-Me-DNJ), 2-oxy-α-D-galactopyranoside-1-DNJ, Fagomine, 1,4-dideoxy-1,4-imino-D-arabinitol, 1,4-dideoxy-1,4-imino-(2-oxy-β-D-pyranoglucoside)-D-arabinitol and 1α, 2β, 3α, 4β-tetrahydroxy-norhygromazine (norhygromazine) and the like; specifically, the mulberry leaf alkaloids include mulberry leaf DNJ (1-deoxynojirimycin).

[0012] In one aspect of the present invention, blank multivesicular liposomes, i.e., multivesicular liposomes (MVLs), are composed of a plurality of non-concentric drug aqueous solution vesicles, which are separated by continuous non-concentric lipid bilayers, and have a high encapsulation rate for both water-soluble drugs and fat-soluble drugs; in particular, multivesicular liposomes release drugs through ruptured vesicles, while the intact vesicles remain intact; the non-concentric topological structure of multivesicular liposomes forms a "reservoir" at the release site, and as the lipid bilayers continue to degrade, the drugs encapsulated therein are gradually released, resulting in a good sustained-release effect while avoiding a burst release effect, and the effect of controlling the drug release time from a few days to a few weeks can also be obtained by adjusting the preparation prescription and process parameters.

[0013] According to the second aspect of this aspect, the present invention provides a method for preparing multivesicular liposomes containing mulberry leaf extract, the method comprising the following steps:

[0014] Step 1: preparing an extracting aqueous solution containing mulberry leaf extract;

[0015] Step 2: mixing the aqueous solution containing the mulberry leaf extract with the oil phase, and preparing a water-in-oil emulsion at a shear rate of 5000-9000 rpm;

[0016] Step 3: slowly injecting the water-in-oil type emulsion into the water phase under stirring to prepare a water-in-oil-in-water type emulsion.

[0017] In one aspect of the present invention, the aqueous extract solution containing mulberry leaf extract is prepared by the following steps:

[0018] Step 1-1: providing mulberry leaves, washing and chopping the mulberry leaves, adding water and beating the leaves to obtain a first mulberry leaf slurry;

[0019] Step 1-2: Grinding the first mulberry leaf slurry to obtain a second mulberry leaf slurry;

[0020] Step 1-3: adding water to the second mulberry leaf slurry, then heating, and performing reflux extraction to obtain a crude aqueous solution containing mulberry leaf extract;

[0021] Step 1-4: subjecting the crude aqueous solution containing mulberry leaf extract to a process of centrifugation, flocculation and membrane filtration to obtain the aqueous solution containing mulberry leaf extract.

[0022] In one aspect of the present invention, in step 1-2, during the grinding process, a sand mill is used for grinding, the rotation speed of the sand mill is 5-10 m / s, the grinding time is 20-60 min, the grinding temperature is 40°C-50°C, and the grinding medium is Φ0.65 mm zirconium oxide grinding beads.

[0023] In one aspect of the present invention, in step 1-2, in the obtained second mulberry leaf slurry, the particle size of the mulberry leaves is 200-400 nm.

[0024] In one aspect of the present invention, in step 1-3, the ratio of the second mulberry leaf slurry to the added water is selected from 1:(1-2).

[0025] In one aspect of the present invention, in step 1-3, the temperature of reflux extraction is 60° C.-80° C., and the extraction time is 1-3 h.

[0026] In one aspect of the present invention, in steps 1-4, the rotation speed during centrifugation is 3000-5000 rpm / min.

[0027] In one aspect of the present invention, in steps 1-4, the crude aqueous solution of the extract containing the mulberry leaf extract can be centrifuged to remove insoluble matter such as fiber and macromolecular protein.

[0028] In one aspect of the present invention, in steps 1-4, the flocculation process requires the addition of a flocculant, and the flocculant includes at least one of chitosan, gum arabic, disodium hydrogen phosphate, trisodium phosphate, zinc sulfate and ferrous sulfate.

[0029] In one aspect of the present invention, in steps 1-4, based on the total mass of the crude aqueous solution containing mulberry leaf extract after centrifugation, the mass percentage of the flocculant used is selected from 0.5‰-3‰.

[0030] In one aspect of the present invention, in step 1-4, a flocculant is added to the crude aqueous solution containing mulberry leaf extract after centrifugation, and then stirred, allowed to stand and centrifuged to obtain a mulberry leaf clarified solution containing mulberry leaf extract.

[0031] In one aspect of the present invention, in steps 1-4, the pore size of the membrane filtration is 200-800D.

[0032] In one aspect of the present invention, in step 2, the aqueous extract solution containing the mulberry leaf extract is heated to fully dissolve its contents, and then mixed with the oil phase and subjected to high-speed shearing to form a stable W / O (water-in-oil) emulsion.

[0033] In one aspect of the present invention, in step 2, the shear rate is selected from 5000-9000 rpm, and the shear time is selected from 5-10 min.

[0034] In one aspect of the present invention, in step 2, the oil phase comprises phospholipids, neutral lipids and an organic solvent; wherein the neutral lipids are selected from at least one of triglycerides, diglycerides, sterols, sterols and tocopherols.

[0035] In one aspect of the present invention, the phospholipid is selected from at least one of lecithin, soybean lecithin, cephalin, dioleoylphosphatidylcholine, hydrogenated soybean lecithin, distearoylphosphatidylcholine, dipalmitoylphosphatidylcholine, dimyristoylphosphatidylcholine, dioleoylphosphatidylcholine, distearoylphosphatidylglycerol, dipalmitoylphosphatidylglycerol, dimyristoylphosphatidylglycerol, dioleoylphosphatidylglycerol and phosphatidylethanolamine.

[0036] In one aspect of the present invention, the neutral lipid is selected from at least one of triolein, tricaprylin, tricaprin, vitamin E and α-tocopherol.

[0037] In one aspect of the present invention, the organic solvent is selected from diethyl ether, dichloromethane, chloroform, ethyl acetate or cyclohexane.

[0038] In one aspect of the present invention, in step 2, the oil phase comprises 50%-70% soybean lecithin, 20%-30% cholesterol, 5%-15% diglyceride, 1%-5% vitamin E and 0.5%-2% ethyl acetate.

[0039] In one aspect of the present invention, in step 3, under magnetic stirring conditions, the W / O type (water-in-oil type) emulsion is slowly injected into the aqueous phase to form a W / O / W type (water-in-oil-in-water type) emulsion.

[0040] In one aspect of the present invention, the aqueous phase contains an osmotic pressure regulator, and the osmotic pressure regulator is selected from at least one of glucose, sucrose, mannitol, sodium chloride, trehalose, succinate, cyclodextrin, arginine, galactose, mannose, maltose, mannitol, glycine, lysine, citrate, sorbitol and dextran.

[0041] In one aspect of the present invention, in step 3, the aqueous phase contains glucose and lysine, wherein the glucose content is 3.5%-5.5% (W / W), and the lysine concentration is 20-30 nmol / L.

[0042] In one aspect of the present invention, in step 3, after obtaining the water-in-oil-in-water type emulsion, it is further subjected to a low-temperature negative pressure vacuum process to remove the organic solvent and a spray drying and powdering step to obtain mulberry leaf extract multivesicular liposomes; the obtained mulberry leaf extract multivesicular liposomes are in powder form.

[0043] According to the third aspect of the present invention, a health food is provided, comprising the aforementioned mulberry leaf extract multivesicular liposomes, or the mulberry leaf extract multivesicular liposomes prepared according to the aforementioned method.

[0044] According to the fourth aspect of the present invention, the present invention provides the use of the aforementioned mulberry leaf extract multivesicular liposomes, the mulberry leaf extract multivesicular liposomes prepared according to the aforementioned method, or the aforementioned health food in lowering blood sugar.

[0045] The beneficial effects of the present invention are:

[0046] (1) The mulberry leaf extract multivesicular liposomes provided by the present invention can simultaneously encapsulate mulberry leaf flavonoids and mulberry leaf DNJ, thereby achieving a better blood sugar lowering effect.

[0047] (2) The multivesicular liposome encapsulation technology provided by the present invention can improve the solubility and bioavailability of mulberry leaf flavonoids, and at the same time improve the sustained release effect of mulberry leaf DNJ; multivesicular liposomes can encapsulate water-soluble mulberry leaf DNJ in aqueous vesicles (i.e., aqueous chambers), and encapsulate fat-soluble mulberry leaf flavonoids in phospholipid bilayers, while achieving dual-component encapsulation of water-soluble and fat-soluble substances, effectively solving the problems of low bioavailability of mulberry leaf flavonoids and short half-life of mulberry leaf DNJ, and improving the overall hypoglycemic effect of mulberry leaves. The interior of the multivesicular liposome is composed of multiple water-containing chambers in the form of non-concentric circles, and each aqueous chamber is separated by a lipid bilayer phospholipid membrane, so that it has good drug loading, encapsulation rate, stability and sustained release effect. Compared with other encapsulation technologies, multivesicular liposomes can exist more stably in the water system.

[0048] (3) Compared with the conventional crushing and ultrafine crushing processes in the prior art, the grinding method provided by the present invention can make the mulberry leaf particle size reach 200-400nm during reflux extraction, greatly increasing the specific surface area of ​​mulberry leaves and extraction solvent, and can make the dissolution rate of mulberry leaf flavonoids and mulberry leaf DNJ in the water extraction process reach more than 95%, thereby solving the problem of low extraction rate of the water extraction process in the prior art.

[0049] (4) The extracted aqueous solution is purified and impurities removed by flocculation and membrane filtration. Compared with the conventional resin purification process (adsorption, elution, concentration) in the prior art, the purification process provided by the present invention is simplified, and the energy consumption caused by the resin purification and concentration process and the loss of effective ingredients under high temperature conditions can be avoided. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 This is a schematic diagram of the structure of the mulberry leaf extract multivesicular liposomes obtained in Example 1 of the present invention.

[0051] Figure 2 This is a line graph showing the effects of different mulberry leaf treatment groups on blood glucose levels in rats in Experimental Example 1 of the present invention.

[0052] Figure 3 This is a bar graph showing the effects of different mulberry leaf treatment groups on the gastrointestinal hormone GLP-1 in rats in Experimental Example 1 of the present invention. DETAILED DESCRIPTION

[0053] The following non-limiting examples can enable those skilled in the art to more fully understand the present invention, but do not limit the present invention in any way. The following content is only an exemplary description of the scope of the present invention, and those skilled in the art can make various changes and modifications to the invention of the present invention based on the disclosed content, and they should also fall within the scope of the present application.

[0054] The present invention is further described below by way of specific examples. The various chemical reagents used in the examples of the present invention are obtained through conventional commercial channels unless otherwise specified. Unless otherwise specified, the contents described below are all weight contents. Unless otherwise specified, it is understood that the process is carried out at room temperature.

[0055] Example

[0056] Embodiment 1:

[0057] Embodiment 1 comprises the following steps:

[0058] Wash and chop fresh mulberry leaves, add a certain proportion of water to pulp them until they are uniform, and form a first mulberry leaf pulp;

[0059] Then, a grinding medium (Φ0.65 mm zirconium oxide grinding beads) was added to the grinding chamber of the sand mill, and the first mulberry leaf slurry was poured into the grinding chamber via a feed pump, and the speed was set to 8 m / s, and the grinding time was 40 min, and nano-grinding was performed to obtain a second mulberry leaf slurry with a particle size of 200-400 nm;

[0060] Add 1.5 times the volume of water to the second mulberry leaf slurry, set the temperature to 60°C, perform heating, stirring and reflux extraction for a total of 3 hours to obtain a crude aqueous solution of the extract;

[0061] Then, the crude extract aqueous solution was centrifuged at 4000 rpm, the supernatant was taken and 0.8‰ chitosan and gum arabic were added for flocculation, and the clarified extract aqueous solution was obtained by filtration, and the clarified extract aqueous solution was filtered through a 600D filter membrane to obtain an extract aqueous solution containing mulberry leaf extract;

[0062] 60% soybean lecithin, 25% cholesterol, 12% diglyceride, and 2% vitamin E were dissolved in 1% ethyl acetate to prepare an oil phase;

[0063] Then the oil phase was poured into the extraction aqueous solution, and sheared at a high shear rate of 8000 rpm for 10 minutes to obtain a stable W / O type colostrum, and then the colostrum was slowly injected into the aqueous phase containing 4% glucose and 25 nmol / L lysine to form a W / O / W type emulsion, and the ethyl acetate organic solvent in the emulsion was removed by low temperature negative pressure vacuum, and the composite emulsion was spray-dried and powdered to obtain the mulberry leaf extract multivesicular liposome powder of Example 1; its structure is as shown in Figure 1 As shown, the interior of the multivesicular liposome contains multiple aqueous chambers and the aqueous chambers are separated by lipid bilayers; mulberry leaf flavonoids are located between the lipid bilayers, and mulberry leaf DNJ is located within the aqueous chambers.

[0064] Embodiment 2:

[0065] Embodiment 2 comprises the following steps:

[0066] Wash and chop fresh mulberry leaves, add a certain proportion of water to pulp them until they are uniform, and form a first mulberry leaf pulp;

[0067] Then, grinding media (Φ0.65 mm zirconium oxide grinding beads) were added to the grinding chamber of the sand mill, and the first mulberry leaf slurry was poured into the grinding chamber via a feed pump, and the speed was set to 6 m / s, and the grinding time was 50 min, and nano-grinding was performed to obtain a second mulberry leaf slurry with a particle size of 200-400 nm;

[0068] Add the same volume of water to the second mulberry leaf slurry, set the temperature to 70°C, perform heating, stirring and reflux extraction for a total of 2 hours, and obtain a crude aqueous solution of the extract;

[0069] Then, the crude extract solution was centrifuged at 5000 rpm, the supernatant was taken and 1.1‰ chitosan and sodium bicarbonate were added for flocculation, and the clarified solution of the extract solution was obtained by filtration, and the clarified solution of the extract solution was filtered through an 800D filter membrane to obtain an extract solution containing mulberry leaf extract;

[0070] Dissolve 55% soybean lecithin, 30% cholesterol, 10% diglyceride, and 3.5% vitamin E in 1.5% ethyl acetate to prepare an oil phase;

[0071] The oil phase was then poured into the extraction aqueous solution and sheared for 10 minutes at a high shear rate of 7000 rpm to obtain a stable W / O type colostrum. The colostrum was then slowly injected into an aqueous phase containing 3.5% glucose and 20 nmol / L lysine to form a W / O / W type double emulsion. The ethyl acetate organic solvent in the double emulsion was removed by low-temperature negative pressure vacuum, and the composite emulsion was spray-dried and powdered to obtain the mulberry leaf extract multivesicular liposome powder of Example 2.

[0072] Embodiment 3:

[0073] Embodiment 3 comprises the following steps:

[0074] Wash and chop fresh mulberry leaves, add a certain proportion of water to pulp them until they are uniform, and form a first mulberry leaf pulp;

[0075] Then, grinding media (Φ0.65 mm zirconium oxide grinding beads) were added into the grinding chamber of the sand mill, and the first mulberry leaf slurry was poured into the grinding chamber via a feed pump, and the rotation speed was set to 10 m / s, and the grinding time was 20 min, and nano-grinding was performed to obtain a second mulberry leaf slurry with a particle size of 200-400 nm;

[0076] Add 2 times the volume of water to the second mulberry leaf slurry, set the temperature to 80°C, perform heating, stirring and reflux extraction for a total of 1 hour to obtain a crude aqueous solution of the extract;

[0077] Then, the crude extract aqueous solution is centrifuged at 3500 rpm, and the supernatant is taken and 2‰ of disodium bicarbonate, octane sulfate and ferrous sulfate are added for flocculation, and the clarified extract aqueous solution is obtained by filtration, and the clarified extract aqueous solution is filtered through a 400D filter membrane to obtain an extract aqueous solution containing mulberry leaf extract;

[0078] 70% soybean lecithin, 20% cholesterol, 6% diglyceride, and 2% vitamin E were dissolved in 2% ethyl acetate to prepare an oil phase;

[0079] The oil phase was then poured into the extraction aqueous solution and sheared at a high shear rate of 9000 rpm for 5 minutes to obtain a stable W / O type colostrum. The colostrum was then slowly injected into an aqueous phase containing 5.5% glucose and 30 nmol / L lysine to form a W / O / W type double emulsion. The ethyl acetate organic solvent in the double emulsion was removed by low-temperature negative pressure vacuum, and the composite emulsion was spray-dried and powdered to obtain the mulberry leaf extract multivesicular liposome powder of Example 3.

[0080] Comparative Example 1:

[0081] Comparative Example 1 comprises the following steps:

[0082] Wash and chop fresh mulberry leaves, add a certain proportion of water to pulp them until they are uniform, and form a first mulberry leaf pulp;

[0083] Then, a grinding medium (Φ0.65 mm zirconium oxide grinding beads) was added to the grinding chamber of the sand mill, and the first mulberry leaf slurry was poured into the grinding chamber via a feed pump, and the speed was set to 8 m / s, and the grinding time was 40 min, and nano-grinding was performed to obtain a second mulberry leaf slurry with a particle size of 200-400 nm;

[0084] Add 1.5 times the volume of water to the second mulberry leaf slurry, set the temperature to 60°C, perform heating, stirring and reflux extraction for a total of 3 hours to obtain a crude aqueous solution of the extract;

[0085] Then, the crude extract solution was centrifuged at 4000 rpm, the supernatant was taken and 0.8‰ chitosan and gum arabic were added for flocculation, the clarified solution of the extract solution was filtered to obtain the clarified solution of the extract solution, and the clarified solution of the extract solution was filtered through a 600D filter membrane to obtain an extract solution containing mulberry leaf extract; the obtained extract solution containing mulberry leaf extract was directly spray-dried and powdered to obtain the mulberry leaf extract powder of Comparative Example 1.

[0086] Experimental Example 1: Animal Experiment

[0087] 1.1 Animal husbandry:

[0088] 24 SPF male SD rats, 7-8 weeks old, weighing 180-200g, were selected; the experimental rats were kept in a room with a temperature of 20℃-25℃, water was changed and feeding was supplemented regularly every day, and all experimental rats were free to drink tap water and eat food. After adapting to this environment for one week, healthy experimental rats with similar weight were selected for subsequent experiments.

[0089] 1.2 Experimental Grouping:

[0090] The rats were randomly divided into a blank group, a mulberry leaf powder group, and a mulberry leaf extract multivesicular liposome group, with 8 mice in each group.

[0091] 1.3 Experimental samples

[0092] The mulberry leaf extract multivesicular liposome powder obtained in Example 1 was selected as the mulberry leaf extract multivesicular liposome group; the mulberry leaf extract powder obtained in Comparative Example 1 was selected as the mulberry leaf powder group.

[0093] 1.4 Experimental steps:

[0094] The multivesicular liposome mulberry leaf powder and conventional mulberry leaf powder were prepared into solutions with the same concentration of mulberry leaf flavonoids and DNJ with sterile water for standby use. First, sucrose was gavaged into the blank group, conventional mulberry leaf group and multivesicular liposome mulberry leaf group rats at a dose of 0.1g / 100g using a gavage needle. After 5 minutes, the rats in the conventional mulberry leaf group and multivesicular liposome mulberry leaf group were gavaged with conventional mulberry leaf powder solution and multivesicular liposome mulberry leaf powder solution, and the administration volume was 1mL / 100g. Sucrose was gavaged before the drug to prevent the body from absorbing and degrading DNJ in advance. After the mice were gavaged, blood was collected from the tail through a blood collection needle, and then the blood glucose level of the mice was measured within 0h, 0.5h, 1h, and 2h using a Roche blood glucose meter. After the blood glucose dropped to normal values, a second gavage (only sucrose solution) was performed, and the blood glucose was measured at 0.5h and once every hour thereafter until the blood glucose dropped to normal values, and the data were recorded to observe the difference in blood glucose changes. After the blood glucose measurement, the rats were anesthetized by intraperitoneal injection of pentobarbital, blood was collected from the abdominal aorta, left to stand at room temperature for 2 hours, centrifuged at 3500 rpm for 10 minutes, and the upper serum was collected and stored at -80°C for later use. According to the instructions, the glucagon-like peptide (GLP-1) ELISA kit was used to determine the GLP-1 content in the serum of rats in each group.

[0095] The experimental results are as follows Figure 2 and 3 As shown in Table 1;

[0096] Table 1 Effects of different groups on rat gastrointestinal hormone GLP-1

[0097] Example GLP-1 (pmol / L) Blank Group 0.88±0.03 Comparative Example 1 <![CDATA[0.98±0.03 * ]]> Example 1 <![CDATA[1.19±0.06 ** ]]>

[0098] Note: Compared with the blank group, *p<0.05, **p<0.01

[0099] according to Figure 2It can be seen that after the first intragastric administration of sucrose, the blood sugar of the blank group reached a maximum value of 12.2mmoL / mL at 0.5h, while the maximum blood sugar values ​​of comparative example 1 and embodiment 1 were significantly lower than those of the blank group, 11.2mmoL / mL and 10.3mmoL / mL respectively. Within 0-3h of the first intragastric administration, the blood sugar value of embodiment 1 < conventional mulberry leaf group < blank group, indicating that after multivesicular liposome treatment, the hypoglycemic effect of mulberry leaf as a whole was significantly improved compared with before; 3h after the second intragastric administration of sucrose, the blood sugar value of the blank group increased rapidly to a maximum value of 12.1mmoL / mL, and the blood sugar value of comparative example 1 at 0.5h was 11.6mmoL / mL, which was lower than that of the blank group, but higher than the blood sugar value of 11.2mol / mL at 0.5h after the first intragastric administration of sucrose, indicating that the hypoglycemic effect of comparative example 1 after the second sucrose intake was significantly reduced, and the main reason was that the DNJ half-life was short and partially metabolized. Compared with the blank group and comparative example 1, the blood glucose concentration of Example 1 was the lowest at 3.5h, which was 9.6mmoL / mL. And it was lower than the blood glucose value at 0.5h after the first intragastric administration of sucrose, indicating that Example 1 had a relatively long effect of inhibiting blood glucose increase, thus proving that the hypoglycemic effect component of mulberry leaves achieved a sustained release effect.

[0100] GLP-1 can lower blood sugar by promoting insulin secretion in the body, delaying gastric emptying, strengthening central appetite suppression and reducing food intake. Figure 3 It can be seen that mulberry leaves can increase the concentration of gastrointestinal hormone GLP-1 in rats; the CLP-1 concentration of comparative example 1 is 0.98 pmol / L, which is 10.2% higher than that of the blank group; the GLP-1 concentration of Example 1 is 1.19 pmol / L, which is 35.2% higher than that of the blank group and 21.4% higher than that of comparative example 1. This indicates that after being treated with multivesicular liposome technology, it can significantly increase the secretion of gastrointestinal hormone GLP-1 in rats and enhance the efficacy of mulberry leaves.

Claims

1. A mulberry leaf extract multivesicular liposome, characterized in that: The mulberry leaf extract multivesicular liposomes contain mulberry leaf extract and blank multivesicular liposomes; the mulberry leaf extract contains mulberry leaf flavonoids and mulberry leaf alkaloids; the blank multivesicular liposomes are composed of a lipid bilayer, and the blank multivesicular liposomes contain a plurality of aqueous chambers, and the aqueous chambers are separated by the lipid bilayers; wherein, The mulberry leaf flavonoids are located between the lipid bilayers, and the mulberry leaf alkaloids are located within the aqueous chamber.

2. The mulberry leaf extract multivesicular liposome according to claim 1, characterized in that: The blank multivesicular liposomes have a particle size of 10-60 μm.

3. The mulberry leaf extract multivesicular liposome according to claim 1, characterized in that: In the mulberry leaf extract multivesicular liposomes, the mass ratio of the mulberry leaf extract to blank multivesicular liposomes is selected from 1:1-1:

5.

4. A method for preparing the mulberry leaf extract multivesicular liposomes according to any one of claims 1 to 3, characterized in that: The method comprises the following steps: Step 1: preparing an extracting aqueous solution containing mulberry leaf extract; Step 2: mixing the aqueous solution containing the mulberry leaf extract with the oil phase, and preparing a water-in-oil emulsion at a shear rate of 5000-9000 rpm; Step 3: slowly injecting the water-in-oil type emulsion into the water phase to prepare a water-in-oil-in-water type emulsion under stirring.

5. The method according to claim 4, characterized in that The aqueous solution containing the mulberry leaf extract is prepared by the following steps: Providing mulberry leaves, washing and chopping the mulberry leaves, adding water and beating the leaves to obtain a first mulberry leaf slurry; Grinding the first mulberry leaf slurry to obtain a second mulberry leaf slurry; adding water to the second mulberry leaf slurry, then heating it, and performing reflux extraction to obtain a crude aqueous solution containing mulberry leaf extract; The crude extract aqueous solution containing mulberry leaf extract is subjected to the processes of centrifugation, flocculation and membrane filtration to obtain the extract aqueous solution containing mulberry leaf extract.

6. The method according to claim 4, characterized in that In step 2, the oil phase contains phospholipids, neutral lipids and an organic solvent; wherein the neutral lipids are selected from at least one of triglycerides, diglycerides, sterols, sterols and tocopherols.

7. The method according to claim 6, characterized in that The phospholipid is selected from at least one of lecithin, soybean lecithin, cephalin, dioleoylphosphatidylcholine, hydrogenated soybean lecithin, distearoylphosphatidylcholine, dipalmitoylphosphatidylcholine, dimyristoylphosphatidylcholine, dioleoylphosphatidylcholine, distearoylphosphatidylglycerol, dipalmitoylphosphatidylglycerol, dimyristoylphosphatidylglycerol, dioleoylphosphatidylglycerol and phosphatidylethanolamine; and / or The neutral lipid is selected from at least one of triolein, tricaprylin, tricaprin, vitamin E and α-tocopherol; and / or The organic solvent is selected from diethyl ether, dichloromethane, chloroform, ethyl acetate or cyclohexane.

8. The method according to claim 4, characterized in that In step 3, the aqueous phase contains an osmotic pressure regulator, and the osmotic pressure regulator is selected from at least one of glucose, sucrose, mannitol, sodium chloride, trehalose, succinate, cyclodextrin, arginine, galactose, mannose, maltose, mannitol, glycine, lysine, citrate, sorbitol and dextran.

9. A health food, characterized in that: The health food comprises the mulberry leaf extract multivesicular liposomes according to any one of claims 1 to 3, or the mulberry leaf extract multivesicular liposomes prepared according to the method according to any one of claims 4 to 8.

10. Use of the mulberry leaf extract multivesicular liposomes according to any one of claims 1 to 3, the mulberry leaf extract multivesicular liposomes prepared according to the method according to any one of claims 4 to 8, or the health food according to claim 9 in lowering blood sugar.

Citation Information

Patent Citations

  • Mulberry leaf extract and its preparing process and application

    CN101036698A

  • Antidiabetics extract, preparing method and uses thereof

    CN101224240A

  • Bulleyaconitine A multivesicular liposome and preparation method thereof

    CN101744765A

  • Compound sulfamonomethoxine sodium multivesicular liposome and preparation method thereof

    CN101836995A

  • Preparation method of lotus leaf-derived natural preservative

    CN107198085A

Cited By

  • Preparation method of chitosan-sodium alginate compound containing plant extract

    CN119157844A

  • Astaxanthin soft capsule with function of reducing blood sugar and preparation process of astaxanthin soft capsule

    CN120000609A